Literature DB >> 16643886

Hearts and bones: shared regulatory mechanisms in heart valve, cartilage, tendon, and bone development.

Joy Lincoln1, Alexander W Lange, Katherine E Yutzey.   

Abstract

The mature heart valves are dynamic structures composed of highly organized cell lineages and extracellular matrices. The discrete architecture of connective tissue within valve leaflets and supporting structures allows the valve to withstand life-long functional demands and changes in hemodynamic forces and load. The dysregulation of ECM organization is a common feature of heart valve disease and can often be linked to genetic defects in matrix protein structure or developmental regulation. Recent studies have identified specific regulatory pathways that are active in the developing valve structures and also control cartilage, tendon, and bone development. This review will focus on the regulatory hierarchies that control normal and abnormal heart valve development in parallel with other connective tissue cell types.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16643886     DOI: 10.1016/j.ydbio.2006.03.027

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  73 in total

1.  Pod1/Tcf21 is regulated by retinoic acid signaling and inhibits differentiation of epicardium-derived cells into smooth muscle in the developing heart.

Authors:  Caitlin M Braitsch; Michelle D Combs; Susan E Quaggin; Katherine E Yutzey
Journal:  Dev Biol       Date:  2012-06-09       Impact factor: 3.582

Review 2.  Transforming growth factor beta signaling in adult cardiovascular diseases and repair.

Authors:  Thomas Doetschman; Joey V Barnett; Raymond B Runyan; Todd D Camenisch; Ronald L Heimark; Henk L Granzier; Simon J Conway; Mohamad Azhar
Journal:  Cell Tissue Res       Date:  2011-09-28       Impact factor: 5.249

3.  Tbx20 regulation of endocardial cushion cell proliferation and extracellular matrix gene expression.

Authors:  Elaine L Shelton; Katherine E Yutzey
Journal:  Dev Biol       Date:  2006-10-03       Impact factor: 3.582

4.  Evidence in favor of linkage to human chromosomal regions 18q, 5q and 13q for bicuspid aortic valve and associated cardiovascular malformations.

Authors:  Lisa J Martin; Vijaya Ramachandran; Linda H Cripe; Robert B Hinton; Gregor Andelfinger; Meredith Tabangin; Kerry Shooner; Mehdi Keddache; D Woodrow Benson
Journal:  Hum Genet       Date:  2007-01-04       Impact factor: 4.132

5.  Periostin promotes atrioventricular mesenchyme matrix invasion and remodeling mediated by integrin signaling through Rho/PI 3-kinase.

Authors:  Jonathan T Butcher; Russell A Norris; Stanley Hoffman; Corey H Mjaatvedt; Roger R Markwald
Journal:  Dev Biol       Date:  2006-10-04       Impact factor: 3.582

6.  Temporal and spatial expression of collagens during murine atrioventricular heart valve development and maintenance.

Authors:  Jacqueline D Peacock; Yinhui Lu; Manuel Koch; Karl E Kadler; Joy Lincoln
Journal:  Dev Dyn       Date:  2008-10       Impact factor: 3.780

7.  Reduced sox9 function promotes heart valve calcification phenotypes in vivo.

Authors:  Jacqueline D Peacock; Agata K Levay; Devin B Gillaspie; Ge Tao; Joy Lincoln
Journal:  Circ Res       Date:  2010-01-07       Impact factor: 17.367

8.  Wnt signaling in heart valve development and osteogenic gene induction.

Authors:  Christina M Alfieri; Jonathan Cheek; Santanu Chakraborty; Katherine E Yutzey
Journal:  Dev Biol       Date:  2009-12-01       Impact factor: 3.582

9.  Insufficient versican cleavage and Smad2 phosphorylation results in bicuspid aortic and pulmonary valves.

Authors:  Loren E Dupuis; Hanna Osinska; Michael B Weinstein; Robert B Hinton; Christine B Kern
Journal:  J Mol Cell Cardiol       Date:  2013-03-24       Impact factor: 5.000

10.  Cartilage link protein 1 (Crtl1), an extracellular matrix component playing an important role in heart development.

Authors:  Elaine E Wirrig; Brian S Snarr; Mastan R Chintalapudi; Jessica L O'neal; Aimee L Phelps; Jeremy L Barth; Victor M Fresco; Christine B Kern; Corey H Mjaatvedt; Bryan P Toole; Stanley Hoffman; Thomas C Trusk; W Scott Argraves; Andy Wessels
Journal:  Dev Biol       Date:  2007-08-09       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.